Please use this identifier to cite or link to this item:
https://hdl.handle.net/20.500.14365/5916| Title: | Amivantamab Plus Lazertinib Vs Osimertinib in First Line, Egfr-Mutant Advanced Nsclc: Patientrelevant Outcomes From Mariposa | Authors: | Nguyen, D. Besse, B. Cho, B. C. Lee, S. -H. Lee, K. H. Lu, S. Garcia Campelo, M. R. |
Publisher: | Elsevier Science inc | URI: | https://hdl.handle.net/20.500.14365/5916 | ISSN: | 1556-0864 1556-1380 |
| Appears in Collections: | WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection |
Show full item record
CORE Recommender
Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.